Implantica announces positive feedback received from U.S. FDA of the RefluxStop™ PMA Module 2 submission

VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces…